C-reactive protein and serum amyloid A protein are the most sensitive and dramatically rising acute phase proteins in man. With the advent of sensitive assays for these proteins their value in the diagnosis and management of disease processes merits study. C-reactive protein is a hepatically produced cyclic pentameric protein whose function is unknown, although it is believed to be concerned in the clearance of autogenous and exogenous material from the circulation. ' range, but were significantly higher than in group 2 patients without lung destruction (p <0.001). Patients with miliary tuberculosis (group 4) also had very high levels, with median values of 2100 U/I for serum amyloid A protein and 105 mg/l for C-reactive protein. These did not differ significantly from those of patients in group 3 with pulmonary destruction.
Patients presenting with tuberculosus pleural effusion (group 5) had some increase in serum amyloid A protein and C-reactive protein levels, with median values of 270 U/I and 35 mg/l. These do not differ significantly from those in group 2 (pulmonary tuberculosis without destruction).
SERIAL SERUM AMYLOID A PROTEIN AND C-REACTIVE PROTEIN LEVELS AFTER TREATM ENT
Serum amyloid A protein levels in seven of the eight patients in group 2 with no overt pulmonary destruction who were studied serially showed a consistent decline towards normal values over 10 days (fig 2) . The levels two days after initiation of treatment were significantly lower than at diagnosis (p < 0-01) Serum amyloid A protein and C-reactive protein levels in pulmonary tuberculosis 199 but did not differ significantly from levels 10 days after treatment had started. In the patient in whom levels did not decline failure to observe the prescribed treatment regimen was suspected, though radiological clearance did result after three months.
Only four of the 11 patients with extensive pulmonary destruction studied serially showed a decrease in serum amyloid A protein levels over the first 10 days (fig 3) . In the other seven patients the levels remained raised. In all 11 patients sputum became negative for tuberculosis. Serum amyloid A protein levels at two, five, and 10 days after the start of treatment did not differ significantly.
Serial measurements of C-reactive protein showed changes which were almost identical to those of serum amyloid A protein in individual patients, declining in the seven patients with no overt pulmonary destruction and in only four of the patients with pulmonary destruction (data not shown).
Discussion
The development of reactive systemic amyloidosis is preceded by a chronic inflammatory state, with high serum amyloid A protein levels maintained over an extended period. In 
